Influenza genetic sequence patents: Where intellectual property clashes with public health needs

Future Virology

Volumn 3, Issue 3, 2008, Pages 235-241

  Andrews, Lori B ^a   Shackelton, Laura A ^a  

^a CHICAGO KENT COLLEGE OF LAW   (United States)

Author keywords

A H5N1; Gene patents; Influenza; Influenza Virus Resource; Intellectual property; Virus genomics; WHO

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ACCESS TO INFORMATION; ANTIVIRAL RESISTANCE; ARTICLE; COURT; DIAGNOSTIC PROCEDURE; GENE SEQUENCE; HEALTH CARE NEED; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LAW SUIT; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; PANDEMIC; PATENT; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEQUENCE ANALYSIS; SEQUENCE DATABASE; UNITED STATES; VIRAL GENETICS; VIRUS STRAIN; ZOONOSIS;

ORTHOMYXOVIRIDAE;

EID: 44149105176     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.3.3.235     Document Type: Article

References (33)

1. Ghedin E, Sengamalay NA, Shumway M et al.: Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437, 1162-1166 (2005).
2. Holmes EC, Ghedin E, Miller N et al.: Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biology 3, e300 (2005).
3. Simonsen L, Viboud C, Grenfell BT et al.: The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol. Biol. Evol. 24, 1811-1820 (2007).
4. Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC: Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathogens 3, 1220-1228 (2007).
5. Chen R, Holmes EC: Avian influenza virus exhibits rapid evolutionary dynamics. Mol. Biol. Evol. 23, 2336-2341 (2006).
6. Fauci AS: Race against time. Nature 435, 423-424 (2005).
7. Bao Y, Bolotov P, Dernovoy D et al.: The Influenza virus resource at the national a center for biotechnology information. J. Virol. 82, 596-601 (2008).
8. Wheeler DL, Barrett T, Benson DA et al.: Database resources of the National Center for Bioitechnology Information. Nucleic Acids Res. 35. D5-Dl2 (2007).
9. No authors listed. Dreams of flu data. Nature 440, 255-256 (2006).
10. 35 United States Code § 101.
11. Diamond v. Diehr, 450 U.S. 175, 185 (1980).
12. 35 United States Code § 102.
13. 35 United States Code § 103.
14. 35 United States Code § 112.
15. 35 United States Code § 154.
16. Simon JH, Claassen E, Correa CE, Osterhaus AD: Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling. Bull. World Health Organ. 83, 707-710 (2005).
17. Jensen K, Murray F: Intellectual property. Enhanced: intellectual property landscape of the human genome. Science 310, 239-240 (2005).
18. Andrews LB: Genes and patent policy: rethinking intellectual property rights. Nat. Rev. Genet. 3, 803-808 (2002).
19. Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF: Effects of patents and licenses on the provision of clinical genetic testing services. J. Mol. Diagn. 5, 3-8 (2003).
20. Benowitz S: French challenge to BRCA1 patent underlies European discontent. J. Natl. Cancer Inst. 94, 80-81 (2002).
21. Gad S, Scheuner MT, Pages-Berhouet S et al.: Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing. J. Med. Genet. 38, 388-392 (2001).
22. Walsh T, Casadei S, Hale Coats K et al.: Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295, 1379-1388 (2006).
23. Pollack A. Flaw seen in genetic test for cancer risk. The New York Times, 22nd March (2006).
24. Rimmer M: The race to patent the SARS virus: the TRIPS agreement and access to essential medicines. Melbourne Journal of International Law 5, 335 (2004).
25. Stix G: Owning the stuff of life. Scientific American, February (2006).
26. U.S. Patent and Trademark Office, Utility Examination Guidelines, 66 Fed. Reg. 1092 (2001).
27. Diamond v. Chakrabarty, 447 U.S. 303 (1980).
28. Lab Corp. of Am. Holdings v. Metabolite Labs, Inc., 548 U.S. 124 (2006).
29. Madey v. Duke University, 307 F.3d 1351 (Fed. Cir. 2002).
30. American Intellectual Property Law Association. 2007 Report of the Economic Survey 22 (2007).
31. Drake JW: Rates of spontaneous mutation among RNA viruses. Proc. Natl Acad. Sci. USA 90, 4171-4175 (1993).
32. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., Ltd., et al., 535 U.S. 722, 731-32, 122 S. Ct. 1831, 1837 (2002).
33. Genomic Research and Accessibility Act, H.R. 977, 110th U.S Congress, 1st Session (February 2007).